Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013, Article ID 382350, 8 pages
http://dx.doi.org/10.1155/2013/382350
Research Article

Absorption and Metabolism Characteristics of Rutin in Caco-2 Cells

1Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaan’xi 710032, China
2Department of Otolaryngology, Shenyang 463 Hospital, Xiao He Yan Road 46, Shenyang, Liaoning 110042, China
3School of Pharmacy, Institute of Materia Medica, Fourth Military Medical University, Xi’an, Shaan’xi 710032, China

Received 17 July 2013; Accepted 25 August 2013

Academic Editors: M. Edery, S. E. Harris, R. B. Petersen, and M. Zarevucka

Copyright © 2013 Xiaofang Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Visioli, C. A. de la Lastra, C. Andres-Lacueva et al., “Polyphenols and human health: a prospectus,” Critical Reviews in Food Science and Nutrition, vol. 51, no. 6, pp. 524–546, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Magrone and E. Jirillo, “Potential application of dietary polyphenols from red wine to attaining healthy ageing,” Current Topics in Medicinal Chemistry, vol. 11, no. 14, pp. 1780–1796, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Asensi, A. Ortega, S. Mena, F. Feddi, and J. M. Estrela, “Natural polyphenols in cancer therapy,” Critical Reviews in Clinical Laboratory Sciences, vol. 48, no. 5-6, pp. 197–216, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Visioli and A. Davalos, “Polyphenols and Cardiovascular disease: a critical summary of the evidence,” Mini-Reviews in Medicinal Chemistry, vol. 11, no. 14, pp. 1186–1190, 2011. View at Google Scholar · View at Scopus
  5. N. Kamalakkannan and P. S. M. Prince, “Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic wistar rats,” Basic and Clinical Pharmacology and Toxicology, vol. 98, no. 1, pp. 97–103, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. C. D. Wu, “Grape products and oral health,” Journal of Nutrition, vol. 139, pp. 1818S–1823S, 2009. View at Google Scholar
  7. S. Sumbul, M. A. Ahmad, M. Asif, and M. Akhtar, “Role of phenolic compounds in peptic ulcer: an overview,” Journal of Pharmacy and Bioallied Sciences, vol. 3, no. 3, pp. 361–367, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Wu, K. Kulkarni, S. Basu, S. Zhang, and M. Hu, “First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics,” Journal of Pharmaceutical Sciences, vol. 100, no. 9, pp. 3655–3681, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. C. S. Yang, S. Sang, J. D. Lambert, and M.-J. Lee, “Bioavailability issues in studying the health effects of plant polyphenolic compounds,” Molecular Nutrition and Food Research, vol. 52, no. 1, pp. S139–S151, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. R. A. J. Darby, R. Callaghan, and R. M. McMahon, “P-glycoprotein inhibition: the past, the present and the future,” Current Drug Metabolism, vol. 12, no. 8, pp. 722–731, 2011. View at Google Scholar · View at Scopus
  11. T. Sakaeda, “MDR1 genotype-related pharmacokinetics: fact or fiction?” Drug Metabolism and Pharmacokinetics, vol. 20, no. 6, pp. 391–414, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. E. M. Wright, D. D. Loo, and B. A. Hirayama, “Biology of human sodium glucose transporters,” Physiological Reviews, vol. 91, no. 2, pp. 733–794, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Ieiri, “Functional significance of genetic polymorphisms in P-glycoprotein (MDR1, ABCB1) and breast cancer resistance protein (BCRP, ABCG2),” Drug Metabolism and Pharmacokinetics, vol. 27, no. 1, pp. 85–105, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. A. I. Alvarez, R. Real, M. Pérez, G. Mendoza, J. G. Prieto, and G. Merino, “Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response,” Journal of Pharmaceutical Sciences, vol. 99, no. 2, pp. 598–617, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Marquez and F. van Bambeke, “ABC multidrug transporters: target for modulation of drug pharmacokinetics and drug-drug interactions,” Current Drug Targets, vol. 12, no. 5, pp. 600–620, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Melaine, M.-O. Liénard, I. Dorval, C. Le Goascogne, H. Lejeune, and B. Jégou, “Multidrug resistance genes and P-glycoprotein in the testis of the rat, mouse, guinea pig, and human,” Biology of Reproduction, vol. 67, no. 6, pp. 1699–1707, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. D. A. Volpe, “Drug-permeability and transporter assays in Caco-2 and MDCK cell lines,” Future Medicinal Chemistry, vol. 3, no. 16, pp. 2063–2077, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Calhau, F. Martel, C. Hipólito-Reis, and I. Azevedo, “Modulation of uptake of organic cationic drugs in cultured human colon adenocarcinoma Caco-2 cells by an ecto-alkaline phosphatase activity,” Journal of Cellular Biochemistry, vol. 87, no. 4, pp. 408–416, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Smetanová, V. Stĕtinová, Z. Svoboda et al., “Caco-2 cells, biopharmaceutics classification system (BCS) and biowaiver,” Acta Medica, vol. 54, pp. 3–8, 2011. View at Google Scholar
  20. A. Crowe and C. Wright, “The impact of P-glycoprotein mediated efflux on absorption of 11 sedating and less-sedating antihistamines using Caco-2 monolayers,” Xenobiotica, vol. 42, no. 6, pp. 538–549, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Ikeda, M. Myotoku, and Y. Hirotani, “Characterization of multidrug resistance-associated protein mRNAs expression profiles in Caco-2 and HT-1080 cell lines induced by methotrexate,” Pharmazie, vol. 63, no. 12, pp. 883–889, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Lampen, B. Ebert, L. Stumkat, J. Jacob, and A. Seidel, “Induction of gene expression of xenobiotic metabolism enzymes and ABC-transport proteins by PAH and a reconstituted PAH mixture in human Caco-2 cells,” Biochimica et Biophysica Acta, vol. 1681, no. 1, pp. 38–46, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Alhamoruni, A. C. Lee, K. L. Wright, M. Larvin, and S. E. O'Sullivan, “Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability,” Journal of Pharmacology and Experimental Therapeutics, vol. 335, no. 1, pp. 92–102, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. J. B. Vaidyanathan and T. Walle, “Cellular uptake and efflux of the tea flavonoid (-)-epicatechin-3-gallate in the human intestinal cell line Caco-2,” Journal of Pharmacology and Experimental Therapeutics, vol. 307, no. 2, pp. 745–752, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. J. M. Young and M. E. Morris, “Pharmacokinetics and bioavailability of the bioflavonoid biochanin A: effects of quercetin and EGCG on biochanin A disposition in rats,” Molecular Pharmaceutics, vol. 4, no. 6, pp. 865–872, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. Q. Ma, E.-Y. Kim, and O. Han, “Bioactive dietary polyphenols decrease heme iron absorption by decreasing basolateral iron release in human intestinal Caco-2 cells,” Journal of Nutrition, vol. 140, no. 6, pp. 1117–1121, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Bielawski, Z. M. Szulc, Y. A. Hannun, and A. Bielawska, “Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry,” Methods, vol. 39, no. 2, pp. 82–91, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. Z. Teng, C. Yuan, F. Zhang et al., “Intestinal absorption and first-pass metabolism of polyphenol compounds in rat and their transport dynamics in caco-2 cells,” PLoS ONE, vol. 7, no. 1, Article ID e29647, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. K. de van Wetering, A. Burkon, W. Feddema et al., “Intestinal breast cancer resistance protein (BCRP)/Bcrp1 and multidrug resistance protein 3 (MRP3)/Mrp3 are involved in the pharmacokinetics of resveratrol,” Molecular Pharmacology, vol. 75, no. 4, pp. 876–885, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Ming, B. M. Knight, and D. R. Thakker, “Vectorial transport of fexofenadine across Caco-2 cells: involvement of apical uptake and basolateral efflux transporters,” Molecular Pharmaceutics, vol. 8, no. 5, pp. 1677–1686, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Stagos, G. Amougias, A. Matakos, A. Spyrou, A. M. Tsatsakis, and D. Kouretas, “Chemoprevention of liver cancer by plant polyphenols,” Food and Chemical Toxicology, vol. 50, no. 6, pp. 2155–2170, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. E. M. Varoni, G. Lodi, A. Sardella, A. Carrassi, and M. Iriti, “Plant polyphenols and oral health: old phytochemicals for new fields,” Current Medicinal Chemistry, vol. 19, no. 11, pp. 1706–1720, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Sun, E. C. Y. Chow, S. Liu, Y. Du, and K. S. Pang, “The Caco-2 cell monolayer: usefulness and limitations,” Expert Opinion on Drug Metabolism and Toxicology, vol. 4, no. 4, pp. 395–411, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. E. F. A. Brandon, T. M. Bosch, M. J. Deenen et al., “Validation of in vitro cell models used in drug metabolism and transport studies; Genotyping of cytochrome P450, phase II enzymes and drug transporter polymorphisms in the human hepatoma (HepG2), ovarian carcinoma (IGROV-1) and colon carcinoma (CaCo-2, LS180) cell lines,” Toxicology and Applied Pharmacology, vol. 211, no. 1, pp. 1–10, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Borlak and C. Zwadlo, “Expression of drug-metabolizing enzymes, nuclear transcription factors and ABC transporters in Caco-2 cells,” Xenobiotica, vol. 33, no. 9, pp. 927–943, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Naruhashi, Y. Kurahashi, Y. Fujita et al., “Comparison of the expression and function of ATP binding cassette transporters in Caco-2 and T84 cells on stimulation by selected endogenous compounds and xenobiotics,” Drug Metabolism and Pharmacokinetics, vol. 26, no. 2, pp. 145–153, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Hilgendorf, G. Ahlin, A. Seithel, P. Artursson, A.-L. Ungell, and J. Karlsson, “Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines,” Drug Metabolism and Disposition, vol. 35, no. 8, pp. 1333–1340, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Berggren, C. Gall, N. Wollnitz et al., “Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine,” Molecular Pharmaceutics, vol. 4, no. 2, pp. 252–257, 2007. View at Publisher · View at Google Scholar · View at Scopus